Combination of active and inactive siRNA targeting the mitotic kinesin Eg5 impairs silencing efficiency in several cancer cell lines

被引:13
作者
Formstecher, Etienne
Reverdy, Celine
Cholay, Mickael
Planquette, Cecile
Trouplin, Virginie
Lehrmann, Heike
Aresta, Sandra
Calabrese, Alessandra
Arar, Khalil
Daviet, Laurent
Colland, Frederic
机构
[1] Hybrigen SA, F-75014 Paris, France
[2] Sigma Proligo, F-75011 Paris, France
关键词
D O I
10.1089/oli.2006.16.387
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Gene silencing by RNA interference (RNAi) has proven to be a powerful tool for investigating gene function in mammalian cells. Combination of several short interfering RNA (siRNA) targeting the same gene is commonly used to improve RNA interference. However, in contrary to the well-described mechanism of RNAi, efficiency of single siRNA compared to pool remains poorly documented. We addressed this issue using several active and inactive siRNA targeting Eg5, a kinesin-related motor involved in mitotic spindle assembly. These siRNA, used alone or in combination, were tested for their silencing efficiency in several cancer cell lines. Here we show that presence of inactive Eg5 siRNA in a pool dramatically decreases knockdown efficacy in a cell line- and dose-dependent manner. Lack of inhibition by unrelated siRNA suggests that a competition may occur during siRNA incorporation into RNA-induced silencing complexes (RISCs) along with the target mRNA. Altogether, our results, which need to be confirmed with additional inactive siRNA, indicate that combination of siRNA may not increase but instead decrease silencing efficiency.
引用
收藏
页码:387 / 394
页数:8
相关论文
共 28 条
[1]   Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening [J].
Aza-Blanc, P ;
Cooper, CL ;
Wagner, K ;
Batalov, S ;
Deveraux, QL ;
Cooke, MP .
MOLECULAR CELL, 2003, 12 (03) :627-637
[2]   A large-scale RNAi screen in human cells identifies new components of the p53 pathway [J].
Berns, K ;
Hijmans, EM ;
Mullenders, J ;
Brummelkamp, TR ;
Velds, A ;
Heimerikx, M ;
Kerkhoven, RM ;
Madiredjo, M ;
Nijkamp, W ;
Weigelt, B ;
Agami, R ;
Ge, W ;
Cavet, G ;
Linsley, PS ;
Beijersbergen, RL ;
Bernards, R .
NATURE, 2004, 428 (6981) :431-437
[3]   Role for a bidentate ribonuclease in the initiation step of RNA interference [J].
Bernstein, E ;
Caudy, AA ;
Hammond, SM ;
Hannon, GJ .
NATURE, 2001, 409 (6818) :363-366
[4]   Innovation - New tools for functional mammalian cancer genetics [J].
Brummelkamp, TR ;
Bernards, R .
NATURE REVIEWS CANCER, 2003, 3 (10) :781-789
[5]   Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB [J].
Brummelkamp, TR ;
Nijman, SMB ;
Dirac, AMG ;
Bernards, R .
NATURE, 2003, 424 (6950) :797-801
[6]   EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer [J].
Clancy, JL ;
Henderson, MJ ;
Russell, AJ ;
Anderson, DW ;
Bova, RJ ;
Campbell, IG ;
Choong, DYH ;
Macdonald, GA ;
Mann, GJ ;
Nolan, T ;
Brady, G ;
Olopade, OI ;
Woollatt, E ;
Davies, MJ ;
Segara, D ;
Hacker, NF ;
Henshall, SM ;
Sutherland, RL ;
Watts, CKW .
ONCOGENE, 2003, 22 (32) :5070-5081
[7]   Functional proteomics mapping of a human signaling pathway [J].
Colland, F ;
Jacq, X ;
Trouplin, V ;
Mougin, C ;
Groizeleau, C ;
Hamburger, A ;
Meil, A ;
Wojcik, J ;
Legrain, P ;
Gauthier, JM .
GENOME RESEARCH, 2004, 14 (07) :1324-1332
[8]   siRNAs: Applications in functional genomics and potential as therapeutics [J].
Dorsett, Y ;
Tuschl, T .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (04) :318-329
[9]   Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells [J].
Elbashir, SM ;
Harborth, J ;
Lendeckel, W ;
Yalcin, A ;
Weber, K ;
Tuschl, T .
NATURE, 2001, 411 (6836) :494-498
[10]   Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans [J].
Fire, A ;
Xu, SQ ;
Montgomery, MK ;
Kostas, SA ;
Driver, SE ;
Mello, CC .
NATURE, 1998, 391 (6669) :806-811